184 related articles for article (PubMed ID: 29093516)
1. Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214.
Huang PS; Lin YH; Chi HC; Chen PY; Huang YH; Yeh CT; Wang CS; Lin KH
Sci Rep; 2017 Nov; 7(1):14868. PubMed ID: 29093516
[TBL] [Abstract][Full Text] [Related]
2. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
Qi Y; Yao X; Du X
IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
4. Repression of microRNA-130b by thyroid hormone enhances cell motility.
Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
[TBL] [Abstract][Full Text] [Related]
5. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
6. The proto-oncogene Pim-1 is a target of miR-33a.
Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK
Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487
[TBL] [Abstract][Full Text] [Related]
7. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
9. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
Wu CH; Yeh CT; Lin KH
Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
[TBL] [Abstract][Full Text] [Related]
11. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
Huang YH; Lin YH; Chi HC; Liao CH; Liao CJ; Wu SM; Chen CY; Tseng YH; Tsai CY; Lin SY; Hung YT; Wang CJ; Lin CD; Lin KH
Cancer Res; 2013 Apr; 73(8):2505-17. PubMed ID: 23442323
[TBL] [Abstract][Full Text] [Related]
13. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
15. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
16. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
17. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.
Yan S; Shan X; Chen K; Liu Y; Yu G; Chen Q; Zeng T; Zhu L; Dang H; Chen F; Ling J; Huang A; Tang H
Gene; 2018 Dec; 679():138-149. PubMed ID: 30098428
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
19. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Rang Z; Yang G; Wang YW; Cui F
Biochem Biophys Res Commun; 2016 May; 474(2):315-320. PubMed ID: 27107696
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]